262 related articles for article (PubMed ID: 25974896)
1. Origin and function of myofibroblasts in the liver.
Wells RG; Schwabe RF
Semin Liver Dis; 2015 May; 35(2):97-106. PubMed ID: 25974896
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
4. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
Mederacke I; Hsu CC; Troeger JS; Huebener P; Mu X; Dapito DH; Pradere JP; Schwabe RF
Nat Commun; 2013; 4():2823. PubMed ID: 24264436
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
Kim WH; Matsumoto K; Bessho K; Nakamura T
Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
[TBL] [Abstract][Full Text] [Related]
6. The origin of fibrogenic myofibroblasts in fibrotic liver.
Kisseleva T
Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
[TBL] [Abstract][Full Text] [Related]
7. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L
Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
[TBL] [Abstract][Full Text] [Related]
9. New therapies for hepatic fibrosis.
Koyama Y; Brenner DA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
[TBL] [Abstract][Full Text] [Related]
10. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts.
Bosselut N; Housset C; Marcelo P; Rey C; Burmester T; Vinh J; Vaubourdolle M; Cadoret A; Baudin B
Proteomics; 2010 Mar; 10(5):1017-28. PubMed ID: 20049859
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis.
Aydın MM; Akçalı KC
Turk J Gastroenterol; 2018 Jan; 29(1):14-21. PubMed ID: 29391303
[TBL] [Abstract][Full Text] [Related]
13. The Origin and Fate of Liver Myofibroblasts.
Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
15. Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.
Vespasiani-Gentilucci U; Carotti S; Perrone G; Mazzarelli C; Galati G; Onetti-Muda A; Picardi A; Morini S
Liver Int; 2015 Feb; 35(2):569-81. PubMed ID: 24649857
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrogenic strategies and the regression of fibrosis.
Kisseleva T; Brenner DA
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):305-17. PubMed ID: 21497747
[TBL] [Abstract][Full Text] [Related]
17. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
Foglia B; Cannito S; Bocca C; Parola M; Novo E
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
[TBL] [Abstract][Full Text] [Related]
18. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
[TBL] [Abstract][Full Text] [Related]
19. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.
Cai X; Wang J; Wang J; Zhou Q; Yang B; He Q; Weng Q
Pharmacol Res; 2020 May; 155():104720. PubMed ID: 32092405
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key.
Bansal MB
Hepatol Int; 2016 Nov; 10(6):902-908. PubMed ID: 27578210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
